Close

Eli Lilly & Co. (LLY), Incyte (INCY) Report Phase 3 RA-BEACON Met Primary Endpoint

Go back to Eli Lilly & Co. (LLY), Incyte (INCY) Report Phase 3 RA-BEACON Met Primary Endpoint